In this special report, Drug Store News takes an in-depth look at community pharmacy and its growing role in helping to lower healthcare costs and expand patient access in the United States.
Pharmacists at Albertsons banner stores in 13 states can dispense Adapt Pharma’s Narcan Nasal Spray and counsel patients on how to use the opioid overdose reversal drug.
Montelukast is used for long-term treatment of asthma in adults and children, and it is sometimes used to treat symptoms of indoor and outdoor allergies.
Approximately 530 Alabama independent drug store owners are seeking relief of as much as $5,000 per store per year in business license fees by excluding prescription sales from gross receipts, according to a report published Friday by the Alabama Media Group. State legislation has been introduced to that end, but is opposed by local municipalities looking at stark revenue reductions. "Cities like Montgomery and Mobile claim the hit would be excessive," the report noted. "In Mobile, city officials estimate that computing a store's gross sales by including prescription medicine has brought in an average of $465,000 annually for the past five years." (AL.com)
Panelists offered perspectives on efforts currently underway to move the healthcare system toward one that rewards innovation, delivers better quality and puts the patient at the center of the value equation.
"This new retail offering complements our virtual care, urgent care and same-day primary care offerings to give consumers more choice for non-emergency services,” Piedmont CEO Kevin Brown said.
Drug retail same-store sales enjoyed a 3.4% increase in the Canadian retailer’s fourth quarter, and increased by 4% for all of 2016.
DIRs are as much about patient access as it is about pharmacy business issues.
The pharmacy staff at cancer-specialized specialty pharmacies have completed a cancer-focused curriculum of advanced education courses, focused on colorectal, lung, prostate and breast cancer, as well as various blood cancers.
Benzer Pharmacy’s program will focus on medication therapy management, chronic disease state management, asthma education and business development.